wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28485457-DBDE0450-FDA7-400F-BD0D-4228F5FE662D
Q28485457-DBDE0450-FDA7-400F-BD0D-4228F5FE662D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28485457-DBDE0450-FDA7-400F-BD0D-4228F5FE662D
Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression
P2860
Q28485457-DBDE0450-FDA7-400F-BD0D-4228F5FE662D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28485457-DBDE0450-FDA7-400F-BD0D-4228F5FE662D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c66f1b20b6453200f9be6ef09888833dccf0f49
P2860
Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.